Initial Disclosure. Within [***] days after the end of the Calendar Quarters ending June 30 and December 31, during the TT Term, GSK shall disclose to Codexis’ Alliance Manager [***] Arising GSK Enzyme Technology and Arising GSK Process Technology, if any.
Appears in 2 contracts
Sources: Platform Technology Transfer, Collaboration and License Agreement (Codexis, Inc.), Platform Technology Transfer, Collaboration and License Agreement (Codexis Inc)